Amid the current situation in Israel, IMP Services remains steadfast in our commitment to support and provide innovative solutions for your clinical trial logistics. Our goal is to ensure seamless operations for your trials, tailored to meet your unique needs.
We’re pleased to share the recent update from the Israeli Ministry of Health. This letter emphasizes the MoH’s dedication to supporting ongoing and new clinical trials despite the current challenges. It stresses the importance of maintaining stability and adherence to regulatory frameworks, ensuring the continuity of critical trials.
Our team and facility are fully operational, supporting importation services without disruption. Hospitals conducting clinical trials in Israel have confirmed the continuation of trials, maintaining necessary infrastructure and operational processes.
We remain committed to keeping you updated on any further developments in the coming weeks. Your continuous support and partnership are deeply appreciated.

Share this article
Blog
Navigating 29C Importation in Israel

What is 29C Importation? Regulation 29C governs the importation of non-registered medicinal products into Israel under specific conditions. This regulation allows hospitals, healthcare providers, and sponsors to access treatments that are not locally registered but are essential for patient care. These imports often support clinical trials, compassionate use programs, or off-label treatments when no registered […]

Blog
Navigating Importation Regulations for Clinical Trials

Importing Investigational Medicinal Products (IMPs) and medical supplies for clinical trials is a complex and highly regulated process. Unlike standard commercial imports, clinical trial importation involves unique regulatory and logistical challenges that require specialized expertise. At IMP, we ensure a seamless and compliant importation process, working closely with regulatory authorities, customs officials, and shipping providers […]

Blog
Navigating Regulatory Differences: The Role of Qualified Persons in Israel and the EU

In the global landscape of clinical trials, regulatory frameworks vary significantly from one region to another. One of the most critical aspects of these frameworks is the role of the Qualified Person (QP), a function that is mandatory in the European Union but differs considerably in other regions, such as Israel. Understanding these differences is […]

Contact Us

    Back to top